Delivery Order SPE2DB24D8003-SPE2DB25FJUBT

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,150.37, is for the delivery of ENTRESTO 97 MG-103 MG tablets. It is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 and a performance period through December 31, 2025. This unrestricted, non-set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $2,206.74 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 60 tablets of the prescription medication Entresto (24 mg-26 mg) to support U.S. Armed Forces medical operations. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S. The ceiling value of this contract is $2,910.31, with an ultimate completion date of October 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract, SPE2DX15D8002|SPE2DX24F2TG3, to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 60 tablets of the drug Entresto (24 mg-26 mg). The contract has a ceiling value of $5,926.14 and a period of performance ending on October 16, 2023. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a broader Indefinite Delivery Contract (IDC) with a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S pharmaceutical products. The contract has a firm fixed-price, with a ceiling value of $8,811.79 and a period of performance through February 24, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00....
The federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,266.56 firm fixed-price delivery order is for the supply of ENTRESTO 24 MG-26 MG TABLET 60S, with a completion date of May 22, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, specifically the medication Entresto 24 mg-26 mg tablets in 60-count bottles. The contract has a total ceiling value of $2,701.93 and a completion date of July 2, 2025. The contract is a firm-fixed price delivery order, and it is not set aside for any...
This is a federal delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,494.32 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 1, 2025, with a completion date of July 2, 2025. The contract is for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S, which is used for the treatment of cardiovascular conditions. Dakota Drug, Inc. is a key supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,208.44 firm-fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUBT
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with an award value of $4,541.04 and a completion date of March 27, 2025, is for the delivery of Entresto 24 mg-26 mg tablets. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. Dakota Drug, Inc. also holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, that enables the company to efficiently deliver critical medical items to various defense healthcare facilities.

Generated 6/29/25, 12:52 AM